Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Krishna R. Gupta
Department of Pharmaceutical Chemistry, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur, IndiaPublications
-
Review
Current Trends in Breast Cancer Treatments
Author(s): Kalyani R. Thombre, Krishna R. Gupta* and Milind J. Umekar
Worldwide, Breast Cancer (BC) remains the most common cancer type accounting for approximately 2.3 million new cases and 685, 000 deaths in 2020. Despite advances in early detection and treatment, breast cancer continues to pose significant challenges due to different molecular subtypes posing different therapeutic challenges. Genetic and hereditary predispositions are among the numerous risk factors linked to the development of breast cancer. The spectrum of breast cancers is very wide. Early-stage breast cancer is thought to be curable and the mainstay of treatment for it is local-regional therapy (radiation and surgery), with systemic therapy administered either before or after surgery as needed. The conventional therapy for early-stage BC is mastectomy alone or breast-conserving surgery coupled with radiation and lymph node, ER, PR and HER-2 status. Breast cancer.. Read More»
DOI: 10.4172/0975-413X.16.5.458-468
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 15261
Der Pharma Chemica received 15261 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
